statistical principles SOP – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Mon, 27 Oct 2025 11:42:47 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for Statistical Principles and Deviations (ICH E9/E9(R1)) https://www.clinicalstudies.in/sop-for-statistical-principles-and-deviations-ich-e9-e9r1/ Mon, 27 Oct 2025 11:42:47 +0000 ]]> https://www.clinicalstudies.in/?p=7097 Read More “SOP for Statistical Principles and Deviations (ICH E9/E9(R1))” »

]]>
SOP for Statistical Principles and Deviations (ICH E9/E9(R1))

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-statistical-principles-and-deviations-ich-e9-e9r1”
},
“headline”: “SOP for Statistical Principles and Deviations (ICH E9/E9(R1))”,
“description”: “This SOP defines standardized procedures for applying statistical principles in clinical trials in compliance with ICH E9 and E9(R1). It outlines requirements for statistical planning, handling of deviations, estimand framework, and documentation for regulatory submissions.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Statistical Principles and Deviations (ICH E9/E9(R1))

SOP No. CR/OPS/157/2025
Supersedes NA
Page No. X of Y
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to provide guidance for the application of statistical principles in clinical trials in accordance with ICH E9 and E9(R1). It defines processes for developing statistical analysis plans, handling deviations, applying the estimand framework, and ensuring robust data interpretation that supports regulatory submissions and scientific validity.

Scope

This SOP applies to sponsors, CROs, biostatisticians, investigators, QA staff, and regulatory affairs professionals engaged in statistical planning, monitoring, and reporting of clinical trial data. It covers development of the Statistical Analysis Plan (SAP), handling protocol deviations, and compliance with ICH E9/E9(R1).

Responsibilities

  • Sponsor: Oversees statistical compliance with ICH E9/E9(R1) and ensures SAP approval.
  • CRO: Executes statistical analyses and ensures timely reporting of deviations.
  • Biostatistician: Develops SAP, applies estimand principles, and conducts statistical analyses.
  • Investigator: Documents site-level deviations impacting statistical analyses.
  • QA: Audits statistical processes for compliance.

Accountability

The Sponsor’s Head of Biostatistics is accountable for ensuring compliance with statistical principles and deviation management in line with ICH E9/E9(R1).

Procedure

1. Statistical Planning
1.1 Develop SAP before database lock.
1.2 Define endpoints, estimands, and statistical methodologies.
1.3 Record in SAP Development Log (Annexure-1).

2. Handling Protocol Deviations
2.1 Identify and classify deviations (major/minor).
2.2 Assess impact on statistical analyses.
2.3 Document in Deviation Impact Log (Annexure-2).

3. Estimand Framework (ICH E9R1)
3.1 Define treatment effect of interest considering intercurrent events.
3.2 Align estimands with trial objectives and endpoints.
3.3 Document in Estimand Framework Log (Annexure-3).

4. Statistical Analysis
4.1 Conduct primary and secondary analyses per SAP.
4.2 Implement sensitivity analyses to account for missing data.
4.3 Document in Analysis Execution Log (Annexure-4).

5. Reporting and Archiving
5.1 Prepare statistical sections of the CSR.
5.2 Archive SAP, deviations, and statistical outputs in TMF.
5.3 Record in Statistical Archiving Log (Annexure-5).

Abbreviations

  • SOP: Standard Operating Procedure
  • SAP: Statistical Analysis Plan
  • ICH: International Council for Harmonisation
  • CSR: Clinical Study Report
  • CRO: Contract Research Organization
  • QA: Quality Assurance
  • TMF: Trial Master File
  • Estimand: A precise description of the treatment effect to be estimated

Documents

  1. SAP Development Log (Annexure-1)
  2. Deviation Impact Log (Annexure-2)
  3. Estimand Framework Log (Annexure-3)
  4. Analysis Execution Log (Annexure-4)
  5. Statistical Archiving Log (Annexure-5)

References

Version: 1.0

Approval Section

Prepared By Ravi Kumar, Biostatistician
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Head Biostatistics

Annexures

Annexure-1: SAP Development Log

Date Protocol ID Activity Prepared By Status
01/09/2025 STAT-2025-01 SAP Drafted Biostatistician Completed

Annexure-2: Deviation Impact Log

Date Deviation Impact Assessment Reviewed By Status
03/09/2025 Missed Visit No Impact Statistician Closed

Annexure-3: Estimand Framework Log

Date Protocol ID Estimand Defined Prepared By Status
05/09/2025 STAT-2025-01 Treatment Effect Adjusted for Dropouts Biostatistician Approved

Annexure-4: Analysis Execution Log

Date Analysis Type Conducted By Status
07/09/2025 Primary Endpoint Statistician Completed

Annexure-5: Statistical Archiving Log

Date Document Archived By Location Status
10/09/2025 SAP and Outputs QA TMF Archived

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Biostatistics

For more SOPs visit: Pharma SOP

]]>